Bank Julius Baer & Co. Ltd, Zurich
BankPosition in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1544599
ZURICH, V8
Position in AUPH
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$49,498
New position
Shares Held
3,340
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank Julius Baer & Co. Ltd, Zurich holds $187,442,451 across 11 Biotechnology names. AUPH ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,406 | $141,734,475 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,973 | $30,112,098 | |
| 3 | BNTX |
BioNTech SE
|
59,947 | $5,328,089 | |
| 4 | MRNA |
Moderna, Inc.
|
93,951 | $4,772,710 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,281 | $4,394,284 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
12,852 | $611,369 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
12,000 | $390,480 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
This page
|
3,340 | $49,498 |
All Filings in AUPH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,498 | 3,340 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||